Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01542528 · ClinicalTrials.gov registry record · NA
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT01542528 is a NA study that has completed, run by Yale University. The registered enrollment target is 117 participants.
The verdict
NCT01542528, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
The investigators are conducting this randomized trial to determine if IBBS (Integrated Brain, Body, and Social)intervention is an effective treatment for ADHD (attention Deficit Hyperactivity Disorder) in two culturally distinct settings; Hamden and New Haven, Connecticut and Beijing, China. A subgroup of the children in the US will also participate in an EEG study before and after IBBS and will be compared to a group of typically developing children. IBBS combines computer-presented brain exercises with a physical education curriculum, all of which is designed to be fun, as well as to enhance sustained attention, inhibitory control and other executive capacities. IBBS is a school-based program in which groups children (composed of children with ADHD, children at risk for ADHD, and typically developing children) alternate between a classroom setting and the gymnasium four days a week for 15 weeks. These mixed age groups will be composed of children with ADHD, children at-risk for ADHD, and typically developing children. Although IBBS takes place in a group setting, the computer game component individualizes instruction to maximize benefit for each child. During the last year of the grant, we will be introducing a pilot study of an organizational skills training (OST) that will provide individualized parent and child training for improved executive functioning in children randomized to the OST plus home-based program.
Interventions
- BEHAVIORAL IBBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01542528
The ClinicalTrials.gov registry entry for NCT01542528 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IBBS is the first listed.
NCT01542528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01542528 about?
NCT01542528 is a clinical study titled "Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)". The investigators are conducting this randomized trial to determine if IBBS (Integrated Brain, Body, and Social)intervention is an effective treatment for ADHD (attention Deficit Hyperactivity Disorder) in two culturally distinct settings; Hamden and New Haven, Connecticut and Beijing, China. A subg...
What is the current status of trial NCT01542528?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2012-03. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01542528?
The interventions under investigation include: IBBS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01542528?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.